|
Volumn 29, Issue 4, 1996, Pages 637-662
|
Postsurgical management of differentiated thyroid carcinoma
a a
a
215 Means Hall
*
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
IODINE 131;
PROTIRELIN;
THYROTROPIN;
THYROXINE;
CANCER MORTALITY;
CANCER RECURRENCE;
CANCER STAGING;
CLINICAL TRIAL;
DYSPHAGIA;
GASTROINTESTINAL SYMPTOM;
HUMAN;
LYMPH NODE METASTASIS;
NECK PAIN;
ORAL DRUG ADMINISTRATION;
OSTEOPOROSIS;
PATIENT SELECTION;
PROGNOSIS;
RECURRENCE RISK;
REVIEW;
RISK ASSESSMENT;
THYROID CARCINOMA;
THYROTOXICOSIS;
TREATMENT OUTCOME;
TREATMENT PLANNING;
ADENOCARCINOMA, FOLLICULAR;
CARCINOMA, PAPILLARY;
CHEMOTHERAPY, ADJUVANT;
FOLLOW-UP STUDIES;
HUMANS;
IODINE RADIOISOTOPES;
POSTOPERATIVE CARE;
PROGNOSIS;
RADIOTHERAPY DOSAGE;
RADIOTHERAPY, ADJUVANT;
THYROGLOBULIN;
THYROID HORMONES;
THYROID NEOPLASMS;
THYROIDECTOMY;
TREATMENT OUTCOME;
|
EID: 0029937128
PISSN: 00306665
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (21)
|
References (0)
|